Screening for hepatitis C in average and high‐risk populations of Qatar using rapid point‐of‐care testing-Reference-Cited by-同舟云学术

Screening for hepatitis C in average and high‐risk populations of Qatar using rapid point‐of‐care testing

Published:2015-08 Issue:4 Volume:3 Page:364-370
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Sharma Manik¹,Al Kaabi Saad¹,John Anil K¹,Al Dweik Nazeeh¹,Ullah Wani Hameed¹,Babu Thandassary Ragesh¹,Derbala Moutaz F¹,Al Ejji Khalid¹,Sultan Khaleel¹,Pasic Fuad¹,Al Mohannadi Munnera¹,Yacoub Rafae¹,Butt Mohd Tariq¹,Singh Rajvir²

Affiliation:

1. Division of Gastroenterology Department of Medicine, Hamad Medical CorporationDoha Qatar

2. Department of CCS Hamad Medical CorporationDoha Qatar

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640615580725

Reference27 articles.

1. The Changing Epidemiology and Natural History of Hepatitis C Virus Infection

2. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

3. Global epidemiology of hepatitis C virus infection

4. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

5. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Sofosbuvir Combined with Direct Acting Antivirals in Hepatitis C Patients in a Tertiary Teaching Hospital in Qatar: A Retrospective Observational Study;Journal of Pharmaceutical Research International;2020-11-30

2. Awareness, Compliance, and Barriers of 1-Time Hepatitis C Screening in Hospital-Based Providers;The Journal for Nurse Practitioners;2020-06

3. The Improvement in 1-Year Survival Rate of Patients with Hepatocellular Carcinoma BCLC Stage A and B after the Implementation of Comprehensive Management;Journal of Gastrointestinal Cancer;2019-09-10

4. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients;Journal of Clinical Pathology;2018-05-05